MacroGenics (NASDAQ:MGNX) Price Target Raised to $24.00
MacroGenics (NASDAQ:MGNX – Free Report) had its price target raised by BTIG Research from $12.00 to $24.00 in a research report released on Monday, MarketBeat Ratings reports. They currently have a buy rating on the biopharmaceutical company’s stock. Other equities analysts also recently issued research reports about the stock. JMP Securities increased their price target […]
More Stories
Air T (NASDAQ:AIRT) Shares Cross Below 200 Day Moving Average – Should You Sell?
Air T, Inc. (NASDAQ:AIRT – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday...
RedHill Biopharma (NASDAQ:RDHL) Share Price Passes Below 200-Day Moving Average – Time to Sell?
RedHill Biopharma Ltd. (NASDAQ:RDHL – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The...
HgCapital Trust (LON:HGT) Share Price Passes Below 200 Day Moving Average – Here’s Why
HgCapital Trust plc (LON:HGT – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The...
S&U (LON:SUS) Stock Price Passes Below 200-Day Moving Average – Should You Sell?
S&U plc (LON:SUS – Get Free Report)’s stock price passed below its two hundred day moving average during trading on...
Oxford Metrics (LON:OMG) Share Price Passes Below Two Hundred Day Moving Average – Here’s Why
Oxford Metrics plc (LON:OMG – Get Free Report) shares crossed below its 200-day moving average during trading on Tuesday ....
James Latham (LON:LTHM) Shares Cross Below 200 Day Moving Average – Should You Sell?
Shares of James Latham plc (LON:LTHM – Get Free Report) passed below its 200-day moving average during trading on Tuesday...